首页 正文

Review Pharmacology & therapeutics. 2021 Oct:226:107878. doi: 10.1016/j.pharmthera.2021.107878 Q112.52025

Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder

大麻环素 vardin 治疗癫痫和自闭症的潜力 翻译改进

Erica Zamberletti  1, Tiziana Rubino  2, Daniela Parolaro  3

作者单位 +展开

作者单位

  • 1 Dept. of Biotechnology and Life Sciences (DBSV) and Neuroscience Center, University of Insubria, Busto Arsizio, Italy. Electronic address: erica.zamberletti@uninsubria.it.
  • 2 Dept. of Biotechnology and Life Sciences (DBSV) and Neuroscience Center, University of Insubria, Busto Arsizio, Italy.
  • 3 Dept. of Biotechnology and Life Sciences (DBSV) and Neuroscience Center, University of Insubria, Busto Arsizio, Italy; Zardi-Gori Foundation, Milan, Italy. Electronic address: dparolaro@fondazionezardigori.com.
  • DOI: 10.1016/j.pharmthera.2021.107878 PMID: 33895189

    摘要 Ai翻译

    Recent years have seen a renewed interest on the possible therapeutic exploitations of specific cannabinoids derived from the Cannabis sativa plant. Thus far, the most studied non-psychotomimetic cannabinoid is cannabidiol (CBD), which has shown promising therapeutic potential for relieving a variety of neurological diseases. However, also its propyl analogue, cannabidivarin (CBDV), has recently gained much attention as a potential therapeutic agent for th... ...点击完成人机验证后继续浏览
    Copyright © Pharmacology & therapeutics. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Pharmacology & therapeutics

    缩写:PHARMACOL THERAPEUT

    ISSN:0163-7258

    e-ISSN:1879-016X

    IF/分区:12.5/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder